Cytology and high-risk human papillomavirus test for cervical cancer screening assessment
FA Stuebs, MC Koch, AK Dietl, W Adler, C Geppert… - Diagnostics, 2022 - mdpi.com
Background: A new nationwide screening strategy was implemented in Germany in January
2020. No data are available for women referred to certified dysplasia units for secondary …
2020. No data are available for women referred to certified dysplasia units for secondary …
Evaluation of primary HPV-based cervical screening among older women: Long-term follow-up of a randomized healthcare policy trial in Sweden
Q Yao, J Wang, KM Elfström, B Strander, J Dillner… - PLoS …, 2024 - journals.plos.org
Background Evidence on invasive cervical cancer prevention among older women is limited,
especially with the introduction of human papillomavirus (HPV)-based screening and longer …
especially with the introduction of human papillomavirus (HPV)-based screening and longer …
[HTML][HTML] MTIOT: Identifying HPV subtypes from multiple infection data
Persistent infection with high-risk human papillomavirus (hrHPV) is a major cause of cervical
cancer. The effectiveness of current HPV-DNA testing, which is crucial for early detection, is …
cancer. The effectiveness of current HPV-DNA testing, which is crucial for early detection, is …
Extended HPV genotyping by the BD Onclarity assay: concordance with screening HPV-DNA assays, triage biomarkers, and histopathology in women from the …
The use of clinically validated human papillomavirus (HPV) assays is recommended in
cervical cancer screening, and extended genotyping is getting attention as a triage …
cervical cancer screening, and extended genotyping is getting attention as a triage …
[HTML][HTML] 宫颈人乳头瘤病毒检测方法的研究进展
刘珺珺， 许宝霖， 张丽 - Advances in Clinical Medicine, 2023 - hanspub.org
宫颈癌是女性群体的高发疾病之一, 我国每年宫颈癌新发病例约10 万例, 是威胁女性健康的重大
疾病. 宫颈癌筛查是促进其早诊断早治疗的有效措施, 基于细胞学的检测是以往筛查方案的基石 …
疾病. 宫颈癌筛查是促进其早诊断早治疗的有效措施, 基于细胞学的检测是以往筛查方案的基石 …